All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news


hiv & aids news selected from other sources

  • Women
    Cash transfers reduce risk of intimate partner violence for young girls in South Africa
    AVERT | 08 March 2018

    Study finds that the risk of physical intimate partner violence (IPV) is reduced by giving regular cash payments to poor girls, but HIV infection rates are not affected.

  • Health services and systems
    Separate and Unequal Access Frames Discussion at CROI Panel on U.S. HIV Care Cascade
    The Body Pro | 08 March 2018

    Attendees of the Monday, March 5, panel at the Conference on Retroviruses and Opportunistic Infections (CROI) discussing the HIV care cascade were probably expecting your usual set of presentations on what we're getting right or wrong about testing, linkage to/retention in care, and viral suppression. Those elements were there. But what was also clear from every presenter (a group that includes both researchers and medical providers) was that the lack of Medicaid expansion in the South is creating worse racial disparities in the U.S.

  • Policy
    More than 200 Scientists, Researchers and Clinicians including the co-discoverer of HIV Denounce Trump Administration Policies that Undermine the Global HIV Response
    Health Gap | 08 March 2018

    More than 200 HIV scientists, researchers and clinicians – including Françoise Barré-Sinoussi, a virologist and Nobel Laureate who co-discovered HIV; Linda-Gail Bekker, President of the International AIDS Society; and the HIV Medicine Association – have signed an open letter to U.S. President Donald Trump denouncing the deterioration of evidence-based policymaking during his administration. The letter was released today on the final day of the annual Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, Massachusetts.

  • Microbicides
    In the Era of Daily PrEP, Feds May Stop Research Funding Gels, Rings, and Douches for HIV Prevention
    The Body | 07 March 2018

    It's precisely because of the overwhelming success in recent years of oral PrEP that the future of the anal douche and other sorts of topically applied anti-HIV agents, such as gels and dissolvable films, all loosely termed "microbicides," is suddenly up in the air, if not outright doomed.

  • Treatment-experienced people
    FDA approves new HIV treatment for patients who have limited treatment options
    FDA | 07 March 2018

    Today, the U.S. Food and Drug Administration approved Trogarzo (ibalizumab-uiyk), a new type of antiretroviral medication for adult patients living with HIV who have tried multiple HIV medications in the past (heavily treatment-experienced) and whose HIV infections cannot be successfully treated with other currently available therapies (multidrug resistant HIV, or MDR HIV).Trogarzo is administered intravenously once every 14 days by a trained medical professional and used in combination with other antiretroviral medications.

  • TB treatment
    Higher rifampin doses safe for patients with pulmonary TB
    Healio | 07 March 2018

    Results of a phase 2 randomized clinical trial show that up to twice the standard daily dose of rifampin was safe in patients with pulmonary tuberculosis. The findings suggest that TB therapy can be shortened using higher doses, which could potentially improve outcomes without increasing toxicity.

  • Outcomes and prognosis
    Issue Brief: Suboptimal Immune Recovery on Antiretroviral Therapy
    TAG | 06 March 2018

    A subset of people on ART experience limited or no recovery of CD4+ T cell counts despite achieving and maintaining undetectable HIV viral loads, and these individuals have an elevated risk of illness and death compared with counterparts who obtain greater CD4+ T cell gains.

  • Bad science and bogus treatments
    Meet SA pastor who has 'cured HIV, ended poverty and walked on air'
    The Star | 06 March 2018

    The 30-something preacher is well aware of the allegations he is little more than a scam artist, but they are accusations he shrugs off. "My ministry is not for everyone, it is for those who have faith," he tells me. "I'm just a messenger of God's work. God heals people in our meetings."

  • How HIV works
    Scientists Find No Signs That Well-Treated HIV Replicates in Lymph Nodes
    Poz | 06 March 2018

    A research team has found no evidence of ongoing HIV replication in the lymph nodes among individuals receiving fully suppressive antiretroviral (ARV) treatment for the virus. This finding stands in sharp contrast to the conclusions of a 2016 study out of Northwestern University, published in Nature, that indicated that even in the face of ARV treatment, HIV replicates in the lymph nodes, thus helping to replenish the viral reservoir.

  • Discrimination and the law
    UK: HIV+ Man Crowdfunds Legal Challenge After Being ‘Refused Appointment’
    RightsInfo | 06 March 2018

    A man who says his dentist refused to see him because of his HIV status is now crowdfunding a legal challenge under the Equality Act.

Conference news

News from the annual Conference on Retroviruses and Opportunistic Infections (CROI 2018).

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Achieving the 90-90-90 target

With advances in HIV testing, treatment and care, some countries are making great progress towards the UNAIDS 90-90-90 target.

New EUROBulletin

Read the December edition of the Sexual Health & HIV Policy EUROBulletin.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.